ABBVAbbVie
Smart Score
How it is scored →The Smart Score (1–10) describes how this instrument compares with its peers on published, rules-based measures of value, quality, trend, stability and dividend safety. It is not a forecast and not personal advice.
Compared with: Health care companies in USA (n = 211)
Current rating first published: · last recomputed · rating log
Factor scores
Percentiles within the peer group (100 = the best of its peers); dividend safety in points.
Main drivers
- Volatility (1 y)supports the score · percentile 96
- Max drawdown (3 y)supports the score · percentile 98
- Betasupports the score · percentile 97
Red flags and notes
- Caution:Dividend cut risk Dividend Safety below 40 points.
- Caution:Dividend outgrows earnings Dividends grew 5+ points a year faster than earnings over five years and the payout is above 75 %.
- Negative equity Book equity is below zero.
Our rules see a meaningful risk that this dividend is cut.
Price chart
Interactive chart by TradingView: exchange prices are delayed, crypto and currencies are live.
Key metrics
Valuation
- P/E
- 79,9
- P/S
- 7,8
- EV/EBIT
- 33,5
- Free-cash-flow yield
- 3,6%
- Market cap (EUR)
- € 447,5 mld.
Profitability and debt
- Return on invested capital
- 20,1%
- Gross margin
- 71,5%
- Net debt / EBITDA
- 2,59
Dividends
- Dividend yield
- 3,02%
- Payout ratio
- 242%
- 5-year dividend growth (per year)
- 5,9%
- Years of dividend growth
- 0
Returns and risk
- 1 day
- +3,3%
- 1 month
- +8,3%
- 1 year
- +27,6%
- Volatility, 1 yr
- 25,7%
- Max drawdown, 1 yr
- −15,7%
- Beta
- 0,44
Ratios from SEC filings and end-of-day prices; returns are price changes without dividends.
News and filings
- AbbVie Inc.: 8-K — Results of operations
FactSEC EDGAR · Filing · 6 okt 2026
- AbbVie Inc.: 8-K — Regulation FD disclosure
FactSEC EDGAR · Filing · 3 sep 2026
- AbbVie Inc.: 8-K — Other events
FactSEC EDGAR · Filing · 19 aug 2026
- AbbVie Inc.: 8-K — Other events
FactSEC EDGAR · Filing · 6 aug 2026
- AbbVie Inc.: 10-Q — Quarterly report for the period ending 2026-06-30
FactSEC EDGAR · Filing · 3 aug 2026
- AbbVie Inc.: 8-K — Results of operations
FactSEC EDGAR · Filing · 31 jul 2026
- FactA filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.
- Media reportA headline from a named media outlet. We link to it and do not check it.
- RumourUnconfirmed: the headline itself hedges (“reportedly”, “sources say”, “in talks”), names no publisher, or comes from a news aggregator or an automated republisher.
Source: Filings: U.S. SEC EDGAR. The tone is scored automatically from the headline and can be wrong.
Score changes in the last 12 months
Every published rating and change, logged when it was published (EU Market Abuse Regulation).
| Date | Event | Balanced | Growth · Income | Warnings | Price at publication |
|---|---|---|---|---|---|
| Rating change | 5/10 | 5 · 1 | — | Available with Invest Pro | |
| Model portfolio change | 5/10 | 5 · 2 | — | Available with Invest Pro | |
| Rating change | 1 → 5/10 | 5 · 2 | removed: Yield trap, Payout above earnings | Available with Invest Pro | |
| First rating | 1/10 | 1 · 1 | Serious warning:Yield trapCaution:Dividend cut riskCaution:Dividend outgrows earningsCaution:Payout above earnings | Available with Invest Pro |
Ratings are rules-based descriptions, valid until the next scoring run (about 06:20 and 21:50 UTC) and the same for every visitor.
Hier opzeggen · EU-consumenten: 14 dagen bedenktijd bij aankoop.